These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23399421)

  • 21. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
    Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
    Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Mullett D; Gallagher N; Sinnathamby M; Yonova I; Moore C; McMenamin J; de Lusignan S; Zambon M
    Euro Surveill; 2016; 21(13):. PubMed ID: 27074651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.
    Castilla J; Martínez-Baz I; Navascués A; Fernandez-Alonso M; Reina G; Guevara M; Chamorro J; Ortega MT; Albéniz E; Pozo F; Ezpeleta C; ;
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.
    Stein Y; Mandelboim M; Sefty H; Pando R; Mendelson E; Shohat T; Glatman-Freedman A;
    Clin Infect Dis; 2018 Apr; 66(9):1383-1391. PubMed ID: 29145568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18.
    Castilla J; Navascués A; Casado I; Pérez-García A; Aguinaga A; Ezpeleta G; Pozo F; Ezpeleta C; Martínez-Baz I; ;
    Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19.
    Chiu SS; Kwan MY; Feng S; Chan EL; Chua H; Wong JS; Peiris JM; Cowling BJ
    Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
    Blyth CC; Macartney KK; Hewagama S; Senenayake S; Friedman ND; Simpson G; Upham J; Kotsimbos T; Kelly P; Cheng AC
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season.
    Englund H; Campe H; Hautmann W
    Epidemiol Infect; 2013 Sep; 141(9):1807-15. PubMed ID: 23098364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virological Characteristics of the 2014/2015 Influenza Season Based on Molecular Analysis of Biological Material Derived from I-MOVE Study.
    Hallmann-Szelińska E; Bednarska K; Korczyńska M; Paradowska-Stankiewicz I; Brydak LB
    Adv Exp Med Biol; 2016; 921():81-5. PubMed ID: 27131497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
    Kissling E; Valenciano M;
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
    Whitaker HJ; Willam N; Cottrell S; Goudie R; Andrews N; Evans J; Moore C; Agrawal U; Hassell K; Gunson R; Zitha J; Anand S; Sebastian-Pillai P; Kalapotharakou P; Okusi C; Hoschler K; Jamie G; Kele B; Hamilton M; Couzens A; Quinot C; Pheasant K; Byford R; Marsh K; Robertson C; de Lusignan S; Williams C; Zambon M; McMenamin J; Watson CH
    Influenza Other Respir Viruses; 2024 May; 18(5):e13295. PubMed ID: 38744684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.